SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hyperliquid is a layer one (L1) blockchain best known for perpetual futures and spot trading. Beyond its flagship DEX trading platform, the ecosystem supports borrowing, lending, real world assets (RWAs), and a full-fledged Ethereum Virtual Machine (EVM), making it a leading force in decentralized finance (defi).   Just as electronic trading dramatically improved markets in the 2000s, Hyperliquid offers an opportunity for a massive technical upgrade of the existing financial system through a transparent, efficient, and resilient blockchain. HYPE is the native token of the Hyperliquid blockchain, with a maximum supply of 1 billion.

Hype

HYPE is drawing significant community attention as investors debate its role as a decentralized perpetual trading powerhouse and a potential high-growth alternative to established assets like Solana and Ethereum. While some traders are focused on short-term price discovery and volatility, others are highlighting the token's growing institutional utility and its integration into new financial products, leading to active discussions about its long-term potential as a core infrastructure play.

Hyliion Holdings Corp. engages in the development of sustainable electricity-producing technology. It focuses on providing modular power plant technology that can operate on various fuel sources through the KARNO power module. The company was founded by Thomas J. Healy in 2015 and is headquartered in Cedar Park, TX.

Hyliion Holdings Corporation - Ordinary Shares - Class A

Hyliion Holdings Corp

Hyliion is seeing significant momentum and retail interest driven by positive financial results and key technological milestones for its KARNO generator, including successful UL certification and expansion into military and data center sectors. Community discussion is heavily focused on the stock's potential as a long-term AI infrastructure play, with investors closely watching for further commercialization updates and institutional re-rating.

What Is Tezos (XTZ)?   Tezos is a high-performing blockchain and open-source platform for assets and applications, with a strong focus on code security, on-chain governance, and decentralization. Tezos 2.0, the upcoming step in the evolution of Tezos, aims to improve scalability (via layer 2s), composability, and to implement support to mainstream programming languages (like Javascript, Typescript, Python, and many others).   Initially built with formal verification in mind, the Tezos protocol enables builders to avoid bugs when developing smart contracts, making it particularly suited to applications that require a high degree of security and certainty.   Tezos’ LPoS (Liquid Proof-of-Stake) consensus mechanism enables any stakeholder to take part, directly or by delegation, in the consensus process, and to be rewarded for securing the network. Rather uniquely, Tezos’ on-chain governance system also enables stakeholders to create and vote on protocol upgrade proposals. This pioneering system allows the protocol to self-amend and upgrade itself without leading to a split (or fork) in the blockchain, empowering the community without slowing down innovation.   First proposed in 2014 and launched in 2018, the Tezos Mainnet has a proven track record of running uninterrupted ever since, having earned a strong reputation for technical excellence and a supportive community.    Who Are the Founders of Tezos? Tezos was conceived by Arthur and Kathleen Breitman in a 2014 white paper under the pseudonym L.M. Goodman in a nod to Satoshi Nakamoto, referencing a journalist who had misidentified the creator of Bitcoin.   In a previous paper, the Breitmans had argued that Bitcoin's biggest shortcomings were the lack of a governance process that invited contributions from its community of users, cost and centralization issues raised by its proof-of-work system, the limited expressiveness of its programming language which didn’t allow for smart contracts, and security

Tezos

Tezos is experiencing high volatility as the community remains deeply divided, with vocal bears celebrating recent downward momentum while bulls look toward long-term staking utility and potential regulatory catalysts. Traders are actively debating whether current price action represents a distribution trap for greedy bag holders or a structural setup for a future recovery.

Brand Engagement Network, Inc. engages in the provision of conversational artificial intelligence assistants with the purpose of transforming engagement and analytics for businesses through security-focused, multimodal communication and human-like artificial intelligence assistants. The firm is also involved in delivering highly personalized, multi-modal artificial intelligence engagement with a focus on industries where there is a massive workforce gap and an opportunity to transform how consumers engage with networks, providers, and brands. The company is founded on March 14, 2024 and is headquartered in Greenwood Village, CO.

Brand Engagement Network Inc

Brand Engagement Network ($BNAI) is trending as investors focus on recent patent grants for AI-driven gesture technology and anticipation regarding a major upcoming acquisition, which community members believe will position the company as a key player in the enterprise AI space. Discussions are heavily focused on high institutional long interest, the potential for a short squeeze driven by a significant cost-to-borrow, and ongoing speculation that the company will secure high-value partnerships within the pharmaceutical sector.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is drawing intense community attention as traders debate whether current price levels present a massive accumulation opportunity or a repetitive pump-and-dump cycle. Investors are actively comparing the token's recent volatility to previous parabolic runs, with many social discussions focused on whale activity, potential short squeezes, and the token's correlation with broader altcoin market movements.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending as investors brace for the latest financial results, with the community closely monitoring institutional buying patterns and long-term pipeline potential despite recent price volatility. Discussions are heavily focused on the company's ability to demonstrate stability in its gene therapy commercial performance and the strategic value of its siRNA platform.

London-based Quant Network is set to revolutionise blockchain technology with the development of their blockchain operating system Overledger. The experienced team are determined to fulfil the original vision of the internet by creating an open trusted network for people, machines, and data to operate securely and safely.  Overledger -the first interoperable blockchain operating system that facilitates internet-scale development of decentralised, multi-chain applications. Overledger has the ability to unlock and distribute value and applications across current and future blockchains. It is an agnostic platform that connects the world's networks to blockchains and ensures you're not limited to any single a vendor or technology. Overledger is the only platform that facilitates the development of internet-scales development of decentralised, multi-chain applications.

Quant

Quant (QNT) is attracting significant attention as investors react to its role in institutional projects like the UK's tokenized deposit pilot and speculation around its limited supply and interoperability. The community remains divided between long-term holders focusing on its enterprise utility and others frustrated by its recent price consolidation and lack of explosive movement compared to broader market trends.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is trending following the announcement of an acquisition by Amazon, with the community actively debating whether the agreed-upon price is an undervaluation of the company's spectrum assets and if an unsolicited higher bid from competing space entities could still materialize. Discussions center on the potential for a bidding war, the strategic integration of Globalstar's technology into Amazons broader network, and the implications of regulatory milestones on the deal's final value.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

The SPDR S&P Biotech ETF is currently garnering significant attention as investors monitor a surge in M&A activity alongside anticipation for clinical data readouts ahead of major upcoming medical conferences. Community sentiment remains focused on identifying undervalued commercial-stage names, with active debate centered on separating companies with genuine long-term clinical potential from those facing binary risk or speculative hype.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

The Russell 2000 is trending as investors digest a mixture of stalled Iran ceasefire negotiations and surging bond yields that are pressuring small-cap debt sensitivity. The community remains deeply divided, with many traders debating whether recent price action is a fundamental breakdown or another buying opportunity amidst ongoing market manipulation discussions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Insider Buying: Nuvilex (NASDAQ:PMCB) Director Acquires 20,000 Shares of Stock

Nuvilex Inc. (NASDAQ:PMCB - Get Free Report) Director Jonathan Schechter purchased 20,000 shares of Nuvilex stock in a transaction that occurred on Monday, January 5th. The shares were bought at an...

PMCB Stock Jumps 25% After Company Sells Stake In Femasys

Equity

PharmaCyte noted that it now has approximately $25 million in marketable securities, in addition to roughly $20 million in cash.


PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes. The company was founded on October 28, 1996 and is headquartered in Las Vegas, NV.

Current Price	$0.81
Prev Close	$0.7961
Open	$0.7855
Dividend Yield	0.00%
50-Day Moving Average	$0.7379
Beta	0.79
Avg. Volume	114,010.48
PE Ratio	-0.78

52-Week High	$1.51
52-Week Low	$0.63
Market Capitalization	$8.7M
EPS (Annual)	$3.19
Price to Book	0.23
Revenue Per Employee	$0.00

PMCB
PharmaCyte Biotech Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Latest PMCB News

PMCBPharmaCyte Biotech Inc